Abacavir + Lamivudine
Composition
The formulation contains Abacavir 120mg + Lamivudine 60mg Tablet: Contains abacavir 120mg and lamivudine 60mg as the active ingredients.
Indications
HIV infection in pediatric patients
Side effects
Hypersensitivity reactions, nausea, headache
Precautions
Screen for HLA-B*5701 allele due to risk of hypersensitivity
Contraindications
Positive HLA-B*5701 allele, moderate to severe liver impairment
Dosage and administration
Based on weight and clinical condition
Countries
UK, India, Australia
Available Forms
Tablets